The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Fluarix Quadrivalent (quadrivalent inactivated “split virus” influenza vaccine; ...

Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of ...

Please provide your email address to receive an email when new articles are posted on . The original formulation of Shingrix consists of two separate vials combined by health care workers prior to ...

Add Yahoo as a preferred source to see more of our stories on Google. If you're 50 or older, you're advised to get immunized to protect yourself from shingles. If the new shingles vaccine made you ...

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...

On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves -- again. The new vaccine, Shingrix, will likely be recommended ...

After the rofecoxib (Vioxx) withdrawal in 2004 made painfully clear how much harm a passive reporting system can miss, ...